Vascular Assessment of Regulation Index Arrays Registry (VARIA)

May 31, 2016 updated by: NeuroChaos Solutions, Inc.
The objective of this patient registry is to collect and analyze physiological data associated with baseline and brain injury identified in standard clinical practice (Normal Values, Recovery Curves, Correlation between Symptoms and Other Tests, NCI Index), and to assess health economics.

Study Overview

Status

Completed

Conditions

Detailed Description

The key aims of the VARIA Registry are to determine the real-life testing patterns and clinical outcomes of newly diagnosed patients with brain injury.

In accordance with the primary objective, the study will collect and analyze physiological data associated with brain injury identified in normal clinical practice with specific reference to:

  • Patient demographics, symptoms, NCI Index, and other test results,
  • Baseline ranges by demographic group,
  • Post-injury patients presenting without a baseline test to be assessed in the context of the norms for similar patients,
  • Recovery curves by demographic,
  • Health Economics.

This registry will be a prospective observational study to collect data to describe the real-life testing patterns and clinical outcomes of newly diagnosed patients with brain injury.

Study Type

Observational

Enrollment (Actual)

13

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Texas
      • Austin, Texas, United States, 78731
        • SportsSafe

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

13 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients contacting a clinic to schedule an appointment for evaluation of the brain (pre or post injury) will be informed about the registry and will be given the option to participate.

Description

Inclusion Criteria:

  • Any patient receiving a Transcranial Doppler for a brain injury
  • Adolescents and Adults
  • Written informed consent obtained by the clinician (may not be required for retrospective cases)

Exclusion Criteria:

  • Alcohol/substance abuse within the past 6 months, patient reported
  • Serious mental illness that might preclude subject's ability to comply with treatment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Concussion with TCD
Any patient (adolescent/adult) receiving a Transcranial Doppler (TCD) for a head injury, suspected concussion, or suspected mild traumatic brain injury (sports related or not).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Neurovascular Complexity Index (NCI) measured by Varia-NCI
Time Frame: Baseline
Patient Neurovascular Complexity Index (NCI) will be measured
Baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Neurovascular Complexity Index (NCI) measured by Varia-NCI
Time Frame: Every 4-7 days post injury; up to 6 months after injury resolution
Patient Neurovascular Complexity Index (NCI) will be measured.
Every 4-7 days post injury; up to 6 months after injury resolution
Cognition measured by clinical praxis
Time Frame: Every 4-7 days post injury; up to 6 months after injury resolution
Patient cognitive status will be measured
Every 4-7 days post injury; up to 6 months after injury resolution
Physiology measured by clinical praxis
Time Frame: Every 4-7 days post injury; up to 6 months after injury resolution
Patient physiological status will be assessed
Every 4-7 days post injury; up to 6 months after injury resolution
Cognition measured by clinical praxis
Time Frame: Baseline
Patient cognitive status will be measured
Baseline
Physiology measured by clinical praxis
Time Frame: Baseline
Patient physiological status will be assessed
Baseline

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Health Economic Outcomes measured by clinical praxis
Time Frame: Every 4-7 days post injury; up to 6 months after injury resolution
Health economic parameters and consumption of resources will be assessed.
Every 4-7 days post injury; up to 6 months after injury resolution

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Vladislav Bukhman, PhD, NeuroChaos Solutions

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2015

Primary Completion (Actual)

May 1, 2016

Study Completion (Actual)

May 1, 2016

Study Registration Dates

First Submitted

April 20, 2015

First Submitted That Met QC Criteria

May 5, 2015

First Posted (Estimate)

May 6, 2015

Study Record Updates

Last Update Posted (Estimate)

June 2, 2016

Last Update Submitted That Met QC Criteria

May 31, 2016

Last Verified

May 1, 2016

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Concussion

3
Subscribe